Glenmede Trust CO Na Santen Pharmaceutical CO Unspo Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$16.05 - $19.12 $37,027 - $44,109	-2,307 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$16.85 - $19.3 $1,954 - $2,238	-116 Reduced 4.79%	2,307 $44,000
Q3 2019 Nov 14, 2019	SELL	$16.9 - $18.04 $3,143 - $3,355	-186 Reduced 7.13%	2,423 $42,000
Q2 2019 Aug 13, 2019	SELL	N/A	-447 Reduced 14.63%	2,609 $43,000
Q1 2019 May 14, 2019	BUY	N/A	1,440 Added 89.11%	3,056 $45,000
Q4 2018 Feb 14, 2019	BUY	N/A	95 Added 6.25%	1,616 $23,000
Q3 2018 Nov 15, 2018	SELL	N/A	-770 Reduced 33.61%	1,521 $24,000
Q2 2018 Aug 15, 2018	BUY	N/A	385 Added 20.2%	2,291 $40,000
Q4 2017 Feb 15, 2018	BUY	N/A	117 Added 6.54%	1,906 $29,000
Q3 2017 Nov 14, 2017	BUY	N/A	1,789	1,789 $0

Others Institutions Holding SNPHY

# of Institutions

3

Shares Held

132

Call Options Held

0

Put Options Held

0

About SANTEN PHARMACEUTICAL CO UNSPO

Ticker SNPHY
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 387,904,992
Market Cap $4.24B

More about SNPHY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.